Page last updated: 2024-12-07

alpha-ocimene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5320249
MeSH IDM0453612

Synonyms (34)

Synonym
1,3,7-octatriene, 3,7-dimethyl-
(3e)-3,7-dimethylocta-1,3,7-triene
(e)-alpha-ocimene
3,7-dimethyl-1,3e,7-octatriene
LMPR0102010023
esj648z6ya ,
einecs 207-957-5
3,7-dimethylocta-1,3,7-triene
alpha-ocimene
unii-esj648z6ya
1,3,7-octatriene, 3,7-dimethyl-, (3e)-
6874-10-8
ocimene trans-alpha-form [mi]
8dbo41sljl ,
alpha-trans-ocimene
trans-alpha-ocimene
alpha-ocimene, (3e)-
unii-8dbo41sljl
alpha-ocimene, (e)-
ocimene trans-alpha-form
trans-.alpha.-ocimene
.alpha.-trans-ocimene
ocimene trans-.alpha.-form [mi]
ocimene, trans-.alpha.-
.alpha.-ocimene, (e)-
ocimene trans-.alpha.-form
.alpha.-ocimene, (3e)-
2,6-dimethyl-1,5,7-octatriene
XJPBRODHZKDRCB-CSKARUKUSA-N
3,7-dimethyl-1,3,7-octatriene #
e-alpha-ocimene
Q26776996
(3e)-alpha-ocimene
DTXSID001042902
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]